<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-BEN-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Benin: Targeted country assistance</narrative>
   <narrative xml:lang="FR">B&#xE9;nin (le): Aide cibl&#xE9;e aux pays</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">GaneshAID</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Benin</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="BJ" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="BJ" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Porto-Novo</narrative>
   </name>
   <administrative code="BJ" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>6.49646 2.60359</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">555362</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">923755</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">690880</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">8533</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="BENPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">84000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">8594</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">290304</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">172464</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-AMP2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">85000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="BENPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">80640</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-GANESHAID2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">18408</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">32664</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">424008</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">283035</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-AMP2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">228983</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="BENPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">60480</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-GANESHAID2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">97583</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">47013</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">186525</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">70296</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BENPEF-TCA-AMP2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">8533</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="BENPEF-TCA-GANESHAID2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003253">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-06"></transaction-date>
   <value currency="USD" value-date="2020-08-06">13922</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">55687</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004360">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-30"></transaction-date>
   <value currency="USD" value-date="2020-11-30">2338</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-13053</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">13053</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001132">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-18"></transaction-date>
   <value currency="USD" value-date="2021-03-18">9891</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001287">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">55687</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003421">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-22"></transaction-date>
   <value currency="USD" value-date="2021-07-22">44506</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003422">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-22"></transaction-date>
   <value currency="USD" value-date="2021-07-22">44506</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004310">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-18"></transaction-date>
   <value currency="USD" value-date="2021-10-18">15457</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004311">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-18"></transaction-date>
   <value currency="USD" value-date="2021-10-18">23495</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000864">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">84000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">80640</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002631">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">60480</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005163">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-08"></transaction-date>
   <value currency="USD" value-date="2020-12-08">14064</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001239">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-25"></transaction-date>
   <value currency="USD" value-date="2021-03-25">21096</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002650">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">7032</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003825">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-12"></transaction-date>
   <value currency="USD" value-date="2021-08-12">7032</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004213">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">14064</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004666">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">11200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-30"></transaction-date>
   <value currency="USD" value-date="2021-11-30">8400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GANESHAID (GaneshAID)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GaneshAID</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">7604</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">15714</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-13113</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">13113</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">781</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">420</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">5063</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000865">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">290304</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">325512</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">98496</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003306">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-13"></transaction-date>
   <value currency="USD" value-date="2021-07-13">186525</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000866">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">172464</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">140598</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">142437</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003404">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-20"></transaction-date>
   <value currency="USD" value-date="2021-07-20">70296</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-benin-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Benin 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-benin-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Benin 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-benin-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Benin 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-benin-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Benin 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-benin-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Benin 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-benin-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Benin 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-benin-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Benin 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-benin-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Benin 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-BEN" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La reprogrammation des fond GAVI est approuv&#xE9;e .

La mise &#xE0; disponition des fonds aux structures operationnelles pour la mise en oeuvre des activit&#xE9;s est effective.

Les rapports financiers et d&apos;audit externe des activit&#xE9;s financ&#xE9;es par l&apos;Alliance GAVI pendant la p&#xE9;riode d&#xE9;clar&#xE9;e sont disponibles.

Les rapports de suivi de la mise en oeuvre des recommandations de l&apos;audit externe est disponible. 

Les rapports de renforcement des capacit&#xE9;s sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcement du syst&#xE8;me de gestion financi&#xE8;re du PEV et pr&#xE9;paration de la transition de la gestion de l&apos;UNICEF au PEV">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">?	Les documents de reprogrammation ont &#xE9;t&#xE9; soumis &#xE0; GAVI pour approbation
?	Les fonds seront mis &#xE0; la disposition des structures op&#xE9;rationnelles pour la mise en ?uvre des activit&#xE9;s apr&#xE8;s approbation de la reprogrammation de GAVI.
?	L?audit des fonds a &#xE9;t&#xE9; fait et le rapport partag&#xE9; avec les principales recommandations partag&#xE9;s avec les acteurs, cet audit a r&#xE9;v&#xE9;l&#xE9; des d&#xE9;penses in&#xE9;ligibles et les remboursements sont en cours</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le dossier pour la reprogrammation des fonds RSS et autres Grants GAVI est soumis;

Les rapports financiers et d&apos;audit externe des activit&#xE9;s financ&#xE9;es par l&apos;Alliance GAVI pendant la p&#xE9;riode d&#xE9;clar&#xE9;e sont disponibles.

Les rapports de suivi de la mise en oeuvre des recommandations de l&apos;audit externe est disponible. 

Les rapports de renforcement des capacit&#xE9;s sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcement du syst&#xE8;me de gestion financi&#xE8;re du PEV et pr&#xE9;paration de la transition de la gestion de l&apos;UNICEF au PEV">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">La validation du rapport du dialogue multipartite, la fin du contrat du consultant comptable s&#xE9;nior et le remboursement des d&#xE9;penses in&#xE9;ligibles de la subvention CARR ont retard&#xE9; la demande de reprogrammation des fonds de renforcement des services de sant&#xE9; (RSS) et autres subventions GAVI.
Les rapports financiers de 2019 et de 2020 ne sont pas encore disponibles. Ils seront valid&#xE9;s par le commissaire aux comptes et puis soumis au Conseil d?administration.
La mise en ?uvre des recommandations de l?audit externe est en cours.
Les diverses mutations au sein de l?Agence nationale des soins de sant&#xE9; primaires (ANSSP) - Directrice g&#xE9;n&#xE9;rale, Directeur administratif et financier et directeurs techniques - ont ralenti la mise en ?uvre du volet financier et du recrutement du nouveau consultant comptable s&#xE9;nior.
Rapports mensuels Gestion financi&#xE8;re ANSSP 
https://drive.google.com/file/d/1u4Fffx4Kk1drr4kpS7qlb9TCkaNMSsUQ/view?usp=sharing
https://drive.google.com/file/d/1K4jw1XYqWIJRt9jajjDFJIwF8EzpNwgC/view?usp=sharing
https://drive.google.com/file/d/18-w0S2z4sG093R3Ai1B3fdAzX3CsbfOj/view?usp=sharing
https://drive.google.com/file/d/1YvIbn-oQ2BS--593XNSRcBlFshFPmzzs/view?usp=sharing 
https://drive.google.com/file/d/1xe0Hl5iBxENDfEc-1Xwa3pbWoFSfUFeb/view?usp=sharing 
https://drive.google.com/file/d/1tun6qdpylqOR9ZrwBlv4f7oLeypzVjo9/view?usp=sharing</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Syst&#xE8;me de surveillance des invaginationales intestinales en place et fonctionnel</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Surveillance des invaginations intestinales aigues">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non d&#xE9;marr&#xE9;e.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mission d&apos;&#xE9;valuation conduite avec rapport final disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Evaluation post campagne/ introduction MenA">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non r&#xE9;alis&#xE9;e en raison du report de la campagne.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapport d&apos;&#xE9;valuation post-campgane disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Evaluation post campagne/ introduction MenA">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Campagne repouss&#xE9;e jusqu&apos;&#xE0; la fin de cette ann&#xE9;e 2021. Le processus est en cours pour la reprogrammation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Evaluation post campagne/ introduction MenA">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Campagne repouss&#xE9;e jusqu&apos;&#xE0; la fin de cette ann&#xE9;e 2021. Le processus est en cours pour la reprogrammation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Evaluation post campagne/ introduction MenA">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">La campagne MenA n&apos;ayant pas eu lieu en 2021 &#xE0; cause du conflit d&apos;agenda engendr&#xE9; par les perturbations li&#xE9;es &#xE0; la gestion de Covid-19, l&apos;enqu&#xEA;te post campagne n&apos;a pu se faire. Cette campagne se fera en 2022 et b&#xE9;n&#xE9;ficiera de l&apos;appui de l&apos;OMS pour l&apos;organisation de l&apos;enqu&#xEA;te.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Carte sanitaire r&#xE9;alis&#xE9;e et valid&#xE9;es par les parties prenantes</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; la r&#xE9;alisation d&apos;une carte sanitaire g&#xE9;or&#xE9;f&#xE9;renc&#xE9;e &#xE0; vis&#xE9;e prospective">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non r&#xE9;alis&#xE9;e, le Minist&#xE8;re de la sant&#xE9; a initi&#xE9; d&apos;autres projets similaires et souhaite &#xE9;voluer avec d&apos;abord.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Personnels des structures de prise en charge des MAPI graves de&#xA0;5 h&#xF4;pitaux de r&#xE9;f&#xE9;rence&#xA0;ont leurs capacit&#xE9;s renforc&#xE9;es.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer&#xA0;les capacit&#xE9;s &#xE0; la prise en charge pr&#xE9;coce et ad&#xE9;quate des&#xA0;MAPI graves (Cible : Agents de sant&#xE9; du secteur priv&#xE9; h&#xF4;pitaux, Points focaux MAPI)">
      <location ref="BJ"></location>
     </target>
     <actual value="Completed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; r&#xE9;alis&#xE9;e en 2 sessions &#xE0; Ouidah et &#xE0; Dassa &#xE0; l&apos;occasion de l&apos;introduction du nouveau vaccin polio (nOPV2).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer&#xA0;les capacit&#xE9;s &#xE0; la prise en charge pr&#xE9;coce et ad&#xE9;quate des&#xA0;MAPI graves (Cible : Agents de sant&#xE9; du secteur priv&#xE9; h&#xF4;pitaux, Points focaux MAPI)">
      <location ref="BJ"></location>
     </target>
     <actual value="Completed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; r&#xE9;alis&#xE9;e en 2 sessions &#xE0; Ouidah et &#xE0; Dassa &#xE0; l&apos;occasion de l&apos;introduction du nouveau vaccin polio (nOPV2).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Propositions &#xE9;labor&#xE9;es et soumises &#xE0; Gavi pour le RR2 et HPV</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration de la proposition HPV et RR2 en routine">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Processus en cours, retard pour la soumission de mai, mais le pays pr&#xE9;sentera son dossier sera pr&#xE9;sent&#xE9; en septembre 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">AMP : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0; 50% of health zones having carried out at least 1 DQS / LQAS,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1: Mapping and directory of immunization stakeholders
Objective 2: Capacity building plan for immunization stakeholders
Objective 3: Accountability framework for health actors">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e dans le TCA 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0; 50% of health zones having performed monthly verification, data analysis</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1: Mapping and directory of immunization stakeholders
Objective 2: Capacity building plan for immunization stakeholders
Objective 3: Accountability framework for health actors">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e dans le TCA 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0; At least 2 of quarterly data harmonization meetings carried out.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1: Mapping and directory of immunization stakeholders
Objective 2: Capacity building plan for immunization stakeholders
Objective 3: Accountability framework for health actors">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e dans le TCA 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0; 50% of health zones having implemented  the current health accountability framework,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1: Mapping and directory of immunization stakeholders
Objective 2: Capacity building plan for immunization stakeholders
Objective 3: Accountability framework for health actors">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Ce qui est fait :
-	Analyse situation des RHS y compris l?analyse du de redevabilit&#xE9; actuel r&#xE9;alis&#xE9;e
-	Base de donn&#xE9;es des acteurs de la vaccination disponible
-	Analyse de situation de besoins de formation
-	Plan renforcement capacit&#xE9;s 
-	Document d?op&#xE9;rationnalisation cadre redevabilit&#xE9; PEV (le cadre de performance valid&#xE9; avec Gavi est celui retenu pour le DG/ANSSP et le DVL)
Prochaines &#xE9;tapes
-	Validation et mise en ?uvre cadre redevabilit&#xE9;
-	Mise en ?uvre du plan de renforcement des capacit&#xE9;s</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0; 50% of health zones having implemented the current health accountability framework,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1: Mapping and directory of immunization stakeholders Objective 2: Capacity building plan for immunization stakeholders Objective 3: Accountability framework for health actors">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support lab testing at national and at least 2 regional labs that have been trained for the detection and characterization of bacterial meningitis and specimen referral;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Benin MOH and National Reference Laboratory, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper specimen management and lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality. 4) provide technical support for preparation and participation of annual meningitis meetings and other meetings">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">All milestones were completed by end of July 2021, which include trainings (20 laboratorians, 3 regions), supervisory visits (5 laboratories), specimen transport, PCR testing, and document control. A virtual training on Laboratory Quality and a QA Implementation meeting were recently provided to Benin to focus on continual improvement of all lab testing processes. Preparation of the 2021-2022 meningitis season is under way and will be completed by December 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluate specimen management and lab testing flows for meningitis within national laboratory network; Develop a standardized program to ensure lab quality and proficiency</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Benin MOH and National Reference Laboratory, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper specimen management and lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality. 4) provide technical support for preparation and participation of annual meningitis meetings and other meetings">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">CDC is working with country partners on operational plans to implement activities and establish timelines. A questionnaire is being developed for proposed assessment on specimen management and testing flows. Standardized programs with a focus on laboratory quality measures are being developed to ensure lab quality and proficiency.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Soumission &#xE9;labor&#xE9;e et pr&#xE9;sent&#xE9;e &#xE0; Gavi &#xE0; bonne date.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le B&#xE9;nin dans le processus d&apos;&#xE9;laboration et de soumission CEF&#xA0;FPP 2019 - 2023">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non programm&#xE9;e par le Minist&#xE8;re de la sant&#xE9;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Outils de collecte &#xE9;labor&#xE9;s, donn&#xE9;es collect&#xE9;es puis analys&#xE9;es, Rapprot pr&#xE9;liminaire disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Fournir l&apos;assistance technique dans le cadre de la coordination de la mise en ?uvre de la revue externe du PEV.">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non programm&#xE9;e par le Minist&#xE8;re de la sant&#xE9;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Soumission approuv&#xE9;e par Gavi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le B&#xE9;nin dans le processus d&apos;&#xE9;laboration et de soumission CEF&#xA0;FPP 2019 - 2023">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non programm&#xE9;e par le Minist&#xE8;re de la sant&#xE9;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Protocole d&apos;&#xE9;valuation &#xE9;labor&#xE9;, TdR et budget &#xE9;labor&#xE9;s, comit&#xE9; de pilotage fonctionnel.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Fournir l&apos;assistance technique dans le cadre de la coordination de la mise en ?uvre de la revue externe du PEV.">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non programm&#xE9;e par le minist&#xE8;re de la sant&#xE9;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TOR du groupe de travail pour l&apos;&#xE9;laboration des documents finalis&#xE9;s, documentations pour soumission constitu&#xE9;es, groupe de travail mis en place et tient ses r&#xE9;unions &#xE0; 100%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le B&#xE9;nin dans le processus d&apos;&#xE9;laboration et de soumission CEF&#xA0;FPP 2019 - 2023">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non retenue par le Minist&#xE8;re de la sant&#xE9;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">R&#xE9;sultats d&#xE9;finitifs de la revue disponible, Rapport final sur l&apos;&#xE9;valuation disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Fournir l&apos;assistance technique dans le cadre de la coordination de la mise en ?uvre de la revue externe du PEV.">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non r&#xE9;alis&#xE9;e.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Cadre de surveillance d&#xE9;fini, acteurs form&#xE9;s sur la d&#xE9;tection des cas d&apos;invagination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Surveillance des invaginations intestinales aigues">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non r&#xE9;alis&#xE9;e.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Protocole &#xE9;labor&#xE9; puis finalis&#xE9;.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Evaluation post campagne/ introduction MenA">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; repouss&#xE9;e pour le dernier trimestre de 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Analyse des donn&#xE9;es effectu&#xE9;es, Recommandations faites pour am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es envisag&#xE9;es.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assistance technique pour la r&#xE9;alisation d&apos;un DQR (desk review)">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Ancienne activit&#xE9; non programm&#xE9;e par le Minist&#xE8;re de la sant&#xE9;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Donn&#xE9;es de couvertures estim&#xE9;es sur une base fiable et logique</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assistance technique pour estimation des couvertures vaccinale, Enqu&#xEA;te de couverture vaccinale dans 2-3 ZS pour validation approche.">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Ancienne activit&#xE9; non programm&#xE9;e.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les dossiers de soumissions HPV; RR2 et FPP sont disponibles et approuv&#xE9; par le CCIA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;laboration des soumissions des vaccins HPV, campagne Rougeole et 2&#xE8;me dose RR, et le FPP ainsi que leur plan d&apos;introduction">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; en cours de pr&#xE9;paration. Le pays n&apos;a pas pu pr&#xE9;senter sa soumission en mai, mais se pr&#xE9;pare pour septembre 2021 pour le RR2.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">les drafts des documents normatifs sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;laboration des documents normatifs du PEV: Directives nationales du PEV, Fiches techniques du PEV, Directives de vaccination dans le contexte Covid,
Directives nationales de supervision, Directives nationales de validation des donn&#xE9;es)">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; non r&#xE9;alis&#xE9;e, pour raison conflit d&apos;agenda.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;laboration des documents normatifs du PEV: Directives nationales du PEV, Fiches techniques du PEV, Directives de vaccination dans le contexte Covid, Directives nationales de supervision, Directives nationales de validation des donn&#xE9;es)">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; a &#xE9;t&#xE9; report&#xE9;e pour la p&#xE9;riode du premier trimestre 2021. Il y avait un probl&#xE8;me de conflit d&apos;agenda avec le dernier ratissage polio organis&#xE9; en septembre 221 et la campagne d acc&#xE9;l&#xE9;ration de la vaccination contre la Covid-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tous les documents normatifs sont valid&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;laboration des documents normatifs du PEV: Directives nationales du PEV, Fiches techniques du PEV, Directives de vaccination dans le contexte Covid,
Directives nationales de supervision, Directives nationales de validation des donn&#xE9;es)">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; a &#xE9;t&#xE9; report&#xE9;e pour la p&#xE9;riode du premier trimestre 2021. Il y avait un probl&#xE8;me de conflit d&apos;agenda avec le dernier ratissage polio organis&#xE9; en septembre 221 et la campagne d acc&#xE9;l&#xE9;ration de la vaccination contre la Covid-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">les dossiers sont soumis a Gavi pour approbation par IRC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;laboration des soumissions des vaccins HPV, campagne Rougeole et 2&#xE8;me dose RR, et le FPP ainsi que leur plan d&apos;introduction">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Document de soumission &#xE9;labor&#xE9; et partag&#xE9; avec IST/WA, des amendements ont faits par IST ont &#xE9;t&#xE9; int&#xE9;gr&#xE9;s, mais la r&#xE9;union de CCIA n&apos;a pu avoir lieu avant la date de soumission du 15 septembre 2021. Le pays se pr&#xE9;pare &#xE0; la soumission de janvier 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60% des communes PEV du pays sont enr&#xF4;l&#xE9;es dans la mise en oeuvre de l&apos;approche Equit&#xE9; avec un focus sur l&apos;atteinte des z&#xE9;ros doses et communes peu ou pas desservies (CPPD). 

100%des microplans equit&#xE9; des communes enroll&#xE9;es sont disponibles.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au renforcement de la gestion du PEV de routine centr&#xE9; sur l&apos;equit&#xE9; dans les 12 d&#xE9;partements avec un focus sur l&apos;atteinte des z&#xE9;ros doses et commune peu ou pas desservies.">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">En 2021, selon la nouvelle approche sur l?&#xE9;quit&#xE9; et les recommandations du dialogue multipartite, il est pr&#xE9;vu d?enr&#xF4;ler 55 communes (60% au lieu de 100% pr&#xE9;vu) abritant &#xE0; la fois les enfants sous-vaccin&#xE9;s et les z&#xE9;ro-dose.
L?&#xE9;laboration des micro plans des communes a &#xE9;t&#xE9; retard&#xE9;e par les reports de la validation du PTA et l?&#xE9;laboration du rapport du dialogue multipartite. Toutefois, les TdR pour leur &#xE9;laboration sont en cours de finalisation et seront transmis &#xE0; l?UNICEF.
&#xC9;tant donn&#xE9; la similarit&#xE9; de ce milestone 6 avec le milestone 3, et que l?objectif est plus proche de celui fix&#xE9; par le pays pour l?ann&#xE9;e 2021, le milestone 6 devrait remplacer le milestone 3 pour les prochains rapports.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">- 100% des formations sanitaires du Benin ont introduit le vaccin Men Afrivac dans le PEV de routine 
- Le document de soumission pour l&apos;introduction de la deuxieme dose de RR et HPV est disponible et soumis &#xE0; GAVI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Appui technique au processus de relance de la vaccination de routine &#xE0; travers un suivi bas&#xE9; sur l&apos;elaboration du dashboard 

2.Appui technique &#xE0; la mise en oeuvre du plan d&apos;elimination de la rougeole, du tetanos maternel et neonatal, de controle de la fievre jaune y compris l&apos;introduction des nouveaux vaccins">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Nous utilisons le status re-programmed car loption non - applicable nest pas disponible.
Ce milestone nest pas applicable pour les raisons suivantes:
La premi&#xE8;re partie du milestone 5 sur le vaccin Men A est d&#xE9;j&#xE0; prise en compte dans le milestone 1.
La deuxi&#xE8;me partie du milestone 5 sur le RR &amp; Human Papilloma Virus (HPV) devait &#xEA;tre assur&#xE9;e par l?OMS, donc ne peut &#xEA;tre rapport&#xE9; par l?UNICEF (GAVI TCA 2021 ligne 9 Colonne I).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">70% des communes PEV du pays sont enr&#xF4;l&#xE9;es dans la mise en oeuvre de l&apos;approche Equit&#xE9; avec un focus sur l&apos;atteinte des z&#xE9;ros doses et les CPPD. 

100%des microplans equit&#xE9; des communes enroll&#xE9;es sont disponibles et mis en ?uvre.

100% des communes enrol&#xE9;es ont atteint une couverture en Penta 3 d&apos;au moins 80%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au renforcement de la gestion du PEV de routine centr&#xE9; sur l&apos;equit&#xE9; dans les 12 d&#xE9;partements avec un focus sur l&apos;atteinte des z&#xE9;ros doses et commune peu ou pas desservies.">
      <location ref="BJ"></location>
     </target>
     <actual value="Completed">
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">- Le document de soumission pour l&apos;introduction de la deuxieme dose de RR et HPV est approuv&#xE9; par GAVI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Appui technique au processus de relance de la vaccination de routine &#xE0; travers un suivi bas&#xE9; sur l&apos;elaboration du dashboard 

2.Appui technique &#xE0; la mise en oeuvre du plan d&apos;elimination de la rougeole, du tetanos maternel et neonatal, de controle de la fievre jaune y compris l&apos;introduction des nouveaux vaccins">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tous les cas de MAPI graves ont fait l&apos;objet de classification par les Experts dans un d&#xE9;lai de 45 apr&#xE8;s leurs survenues.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assurer une prise en charge ad&#xE9;quate en cas de survenue de MAPI graves">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">En cours, le comit&#xE9; des Experts se r&#xE9;unit mensuellement pour &#xE9;tablir l&apos;imputabilit&#xE9; des cas de MAPI graves. Des r&#xE9;unions extraordinaires sont organis&#xE9;es lors des campagnes de vaccination.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assurer une prise en charge ad&#xE9;quate en cas de survenue de MAPI graves">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">En cours, le comit&#xE9; des Experts se r&#xE9;unit mensuellement pour &#xE9;tablir l&apos;imputabilit&#xE9; des cas de MAPI graves. Des r&#xE9;unions extraordinaires sont organis&#xE9;es lors des campagnes de vaccination.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Donn&#xE9;es de l&apos;enqu&#xEA;te utilis&#xE9;es pour les planifications et l&apos;&#xE9;alboration du document de Justification du Soutien au Programme</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduire une enqu&#xEA;te CAP dans les communes.">
      <location ref="BJ"></location>
     </target>
     <actual value="Completed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Enqu&#xEA;te conduite sous la Direction de l&apos;Agence Nationale des Soins de Sant&#xE9; Primaires (ANSSP).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduire une enqu&#xEA;te CAP dans les communes.">
      <location ref="BJ"></location>
     </target>
     <actual value="Completed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Enqu&#xEA;te conduite sous la Direction de l&apos;Agence Nationale des Soins de Sant&#xE9; Primaires (ANSSP).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">AMP : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The maintenance plan is operationalized with 80% of the activities implemented in 50% of  HZ</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 4 and 5">
      <location ref="BJ"></location>
     </target>
     <actual value="Completed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">-	Document d?op&#xE9;rationnalisation du plan de maintenance (normes et proc&#xE9;dure, outils, syst&#xE8;me de suivi -&#xE9;valuation, r&#xE9;f&#xE9;rentiel des comp&#xE9;tences) &#xE9;labor&#xE9;
-	Formation des acteurs pr&#xE9;vue dans le plan de formation</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 4 and 5">
      <location ref="BJ"></location>
     </target>
     <actual value="Completed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">-	Document d?op&#xE9;rationnalisation du plan de maintenance (normes et proc&#xE9;dure, outils, syst&#xE8;me de suivi -&#xE9;valuation, r&#xE9;f&#xE9;rentiel des comp&#xE9;tences) &#xE9;labor&#xE9;
-	Formation des acteurs pr&#xE9;vue dans le plan de formation</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the implementation of an optimization plan of 50 % of HZ are available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 4 and 5">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Le protocole d?analyse de situation dans les zones sanitaires &#xE9;labor&#xE9;.
Le processus n?a pas pu se poursuivre pour d&#xE9;faut de mise &#xE0; disposition du budget</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 4 and 5">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Le protocole d?analyse de situation dans les zones sanitaires &#xE9;labor&#xE9;.
Le processus n?a pas pu se poursuivre pour d&#xE9;faut de mise &#xE0; disposition du budget</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">AMP : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0; The maintenance plan is operationalized with 80% of the activities implemented in 50% of  HZ</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 4: Implementation of the Optimized Logistics System at national level
Objective 5: Operationalization of the maintenance plan for cold chain equipment">
      <location ref="BJ"></location>
     </target>
     <actual value="Completed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">-	Document d?op&#xE9;rationnalisation du plan de maintenance (normes et proc&#xE9;dure, outils, syst&#xE8;me de suivi -&#xE9;valuation, r&#xE9;f&#xE9;rentiel des comp&#xE9;tences) &#xE9;labor&#xE9;
-	Formation des acteurs pr&#xE9;vue dans le plan de formation</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the implementation of an optimization plan of 50 % of HZ are available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 4: Implementation of the Optimized Logistics System at national level
Objective 5: Operationalization of the maintenance plan for cold chain equipment">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Le protocole d?analyse de situation dans les zones sanitaires &#xE9;labor&#xE9;.
Le processus n?a pas pu se poursuivre pour d&#xE9;faut de mise &#xE0; disposition du budget</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapports mensuels de mise en oeuvre du syst&#xE8;me logistique optimis&#xE9; dans le pays sont disponible avec actions correctrices
Le tableau de bord des indicateurs logistiques est mis &#xE0; jour</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Appui &#xE0; la poursuite du Syst&#xE8;me Logistique optimis&#xE9; et monitoring dans le pays avec un focus sur les d&#xE9;partements nouvellement enrol&#xE9;s (Zou, Borgou et Alibori)


2- Appui &#xE0; la mise en place de la Gestion decentralis&#xE9;e des vaccins dans les formations sanitaires">
      <location ref="BJ"></location>
     </target>
     <actual value="Completed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">?	Le syst&#xE8;me logistique optimis&#xE9; est en cours de d&#xE9;ploiement au niveau des zones sanitaires du pays et avec l?appui technique et financier de l?UNICEF dans 10 zones sanitaires sur les 17. Actuellement, il est mis en ?uvre dans 17 zones sanitaires sur les 34 que compte le pays soit 50%. 
?	Les distributions mensuelles de vaccins et intrants aux formations sanitaires &#xE0; travers le syst&#xE8;me sont r&#xE9;guli&#xE8;rement faites par les logisticiens de sant&#xE9; des zones sanitaires. 
?	Des rapports mensuels de mise en ?uvre sont r&#xE9;guli&#xE8;rement produits.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Appui &#xE0; la poursuite du Syst&#xE8;me Logistique optimis&#xE9; et monitoring dans le pays avec un focus sur les d&#xE9;partements nouvellement enrol&#xE9;s (Zou, Borgou et Alibori)


2- Appui &#xE0; la mise en place de la Gestion decentralis&#xE9;e des vaccins dans les formations sanitaires">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Le syst&#xE8;me logistique optimis&#xE9; a d&#xE9;marr&#xE9; en 2015 au B&#xE9;nin pour 34 zones sanitaires:
?	Phase 1 : 11 zones en 2015
?	Phase 2 : 8 zones en 2016
?	Phase 3 : 8 zones en 2017
?	Phase 4 : 7 zones en 2018
2020. 482 r&#xE9;frig&#xE9;rateurs, dont 368 Dulas et 114 B M&#xE9;dical, ont &#xE9;t&#xE9; distribu&#xE9;s dans le pays amenant ainsi la couverture en &#xE9;quipement de chaine de froid pr&#xE9;-qualifi&#xE9; standard (PQS) de 26 % &#xE0; 53%.
Janvier 2020 &#xE0; f&#xE9;vrier 2021. La direction du PEV a b&#xE9;n&#xE9;fici&#xE9; de l?appui technique d?un consultant logisticien national recrut&#xE9; par l?UNICEF pour la mise en ?uvre du syst&#xE8;me logistique optimis&#xE9; (DSLO) et du suivi de la premi&#xE8;re phase du Cold Chain Equipment Optimization Platform (CCEOP) de GAVI.
&#xC0; ce jour, le DSLO ne couvre que 17 zones sanitaires sur les 34, soit 50%.
Des rapports mensuels de mise en ?uvre ont &#xE9;t&#xE9; produits tout comme un rapport synth&#xE8;se de fin de mission pour le DSLO et le CCEOP.
Rapport CCEOP, DSLO et CDF mars 2020
https://drive.google.com/file/d/14u_oxP-NQCmrStj6xFtIqR180lq3IDZh/view?usp=sharing 
Rapport CCEOP Analyse donn&#xE9;es et Plan de r&#xE9;solution
https://drive.google.com/file/d/1X0cTdJoIZGg_I2rl1W76UcoZiLKL8FGv/view?usp=sharing 
Rapport CCEOP, DSLO et CDF juin 2020
https://drive.google.com/file/d/1grZV4lEY9TblrwUBz2HYEkmwNThsy9GN/view?usp=sharing</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les passations de march&#xE9;s prevues au niveau du plan &#xA0;2019 de l&apos;ANV SSP sont execut&#xE9;es &#xE0; 100 %</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au procesus de passation des marches au niveau de l&apos;Agence national de vaccination">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Les passations de march&#xE9;s pr&#xE9;vues dans le plan de l&apos;Agence nationale de la vaccination et des soins de sant&#xE9; primaires (maintenant ANSSP) de 2019 n?ont pas &#xE9;t&#xE9; ex&#xE9;cut&#xE9;es.
En 2020, suite &#xE0; la COVID-19 et la restructuration de lANSSP, les march&#xE9;s ont &#xE9;t&#xE9; recentr&#xE9;s sur les activit&#xE9;s GAVI pour atteindre 100%.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - Financial Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">les rapports financiers et d&apos;audit externe des activit&#xE9;s financ&#xE9;es par l&apos;Alliance GAVI pendant la p&#xE9;riode d&#xE9;clar&#xE9;e peuvent &#xEA;tre examin&#xE9;s pendant l&apos;&#xE9;valuation conjointe Les rapports de renforcement des capacit&#xE9;s sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcement du syst&#xE8;me de gestion financi&#xE8;re du PEV et pr&#xE9;paration de la transition de la gestion de l&apos;UNICEF au PEV">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Les rapports d?audits de la campagne anti rougeoleuse rub&#xE9;ole (CARR) sont partag&#xE9;s avec tous les partenaires. 
Le suivi des recommandations mentionne le remboursement des d&#xE9;penses d&#xE9;clar&#xE9;es in&#xE9;ligibles (93%).
Les rapports de formations sur le PEV, suivant le plan &#xE9;labor&#xE9; par l?&#xE9;quipe de l?ANSSP avec l?appui de l?UNICEF, sont en cours de validation. 
Rapport Enqu&#xEA;te couverture vaccinale post CARR
https://drive.google.com/file/d/1MRbwRj4nvhI7Nrvx5KL6elVpYTsoUqjj/view?usp=sharing 
Rapports d?audit CARR
https://drive.google.com/file/d/102dIw8W3rl2xuk4FfvTFUrAGQyctwHLg/view?usp=sharing
https://drive.google.com/file/d/1riPvMKkOFt3CYAhcLBbpGKY10-ItyUo7/view?usp=sharing
https://drive.google.com/file/d/1IoYM2lsC8ZXV8YHq9jKj-SnnkK3aTnNY/view?usp=sharing
https://drive.google.com/file/d/1N1tsgvNLo1ZZtlWYVhv7S3Auh1aZH2oq/view?usp=sharing
https://drive.google.com/file/d/187YQf6dqNEWxw9CicLBc4RSg66NZ1Z_I/view?usp=sharing
https://drive.google.com/file/d/12zCuUd5uR6tpOiFNzYX-F2tFouEZnsnL/view?usp=sharing
https://drive.google.com/file/d/1hXLSPnZdpzvFgf2FyVmxCtBSccN-P31d/view?usp=sharing
https://drive.google.com/file/d/1sV79cv0C0CaVg5e2em51oI2t_21phsmf/view?usp=sharing
https://drive.google.com/file/d/1_-zlVPVlM6Y1IsbsPyagFg4viFL9BsbA/view?usp=sharing
https://drive.google.com/file/d/1o0Sm5N1p8Hpc7XnbFpYnhuPd9XsAPI8G/view?usp=sharing
https://drive.google.com/file/d/1d--A_uS9b-bpoSr0CbkE3uw0HNxamQmw/view?usp=sharing
https://drive.google.com/file/d/1f5sh9gpb91g2Nz-HTBXFqGWUEbypbnRC/view?usp=sharing
https://drive.google.com/file/d/1268w5zG3tRfyiLyQECWs1_7usFTQDcZJ/view?usp=sharing</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcement du syst&#xE8;me de gestion financi&#xE8;re du PEV et pr&#xE9;paration de la transition de la gestion de l&apos;UNICEF au PEV">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Les rapports d?audits de la campagne anti rougeoleuse rub&#xE9;ole (CARR) sont partag&#xE9;s avec tous les partenaires. 
Le suivi des recommandations mentionne le remboursement des d&#xE9;penses d&#xE9;clar&#xE9;es in&#xE9;ligibles (93%).
Les rapports de formations sur le PEV, suivant le plan &#xE9;labor&#xE9; par l?&#xE9;quipe de l?ANSSP avec l?appui de l?UNICEF, sont en cours de validation. 
Rapport Enqu&#xEA;te couverture vaccinale post CARR
https://drive.google.com/file/d/1MRbwRj4nvhI7Nrvx5KL6elVpYTsoUqjj/view?usp=sharing 
Rapports d?audit CARR
https://drive.google.com/file/d/102dIw8W3rl2xuk4FfvTFUrAGQyctwHLg/view?usp=sharing
https://drive.google.com/file/d/1riPvMKkOFt3CYAhcLBbpGKY10-ItyUo7/view?usp=sharing
https://drive.google.com/file/d/1IoYM2lsC8ZXV8YHq9jKj-SnnkK3aTnNY/view?usp=sharing
https://drive.google.com/file/d/1N1tsgvNLo1ZZtlWYVhv7S3Auh1aZH2oq/view?usp=sharing
https://drive.google.com/file/d/187YQf6dqNEWxw9CicLBc4RSg66NZ1Z_I/view?usp=sharing
https://drive.google.com/file/d/12zCuUd5uR6tpOiFNzYX-F2tFouEZnsnL/view?usp=sharing
https://drive.google.com/file/d/1hXLSPnZdpzvFgf2FyVmxCtBSccN-P31d/view?usp=sharing
https://drive.google.com/file/d/1sV79cv0C0CaVg5e2em51oI2t_21phsmf/view?usp=sharing
https://drive.google.com/file/d/1_-zlVPVlM6Y1IsbsPyagFg4viFL9BsbA/view?usp=sharing
https://drive.google.com/file/d/1o0Sm5N1p8Hpc7XnbFpYnhuPd9XsAPI8G/view?usp=sharing
https://drive.google.com/file/d/1d--A_uS9b-bpoSr0CbkE3uw0HNxamQmw/view?usp=sharing
https://drive.google.com/file/d/1f5sh9gpb91g2Nz-HTBXFqGWUEbypbnRC/view?usp=sharing
https://drive.google.com/file/d/1268w5zG3tRfyiLyQECWs1_7usFTQDcZJ/view?usp=sharing</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">les rapports financiers et d&apos;audit externe des activit&#xE9;s financ&#xE9;es par l&apos;Alliance GAVI pendant la p&#xE9;riode d&#xE9;clar&#xE9;e peuvent &#xEA;tre examin&#xE9;s pendant l&apos;&#xE9;valuation conjointe Le syst&#xE8;me fudiciaire est mis en place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcement du syst&#xE8;me de gestion financi&#xE8;re du PEV et pr&#xE9;paration de la transition de la gestion de l&apos;UNICEF au PEV">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Nous utilisons le status re-programmed car loption non - applicable nest pas disponible.
Ce milestone nest pas applicable du fait quil est une duplication du milestone 4 dej&#xE0; rapport&#xE9; ci-dessus.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">- 100% des formations sanitaires du Benin ont introduit le vaccin Men Afrivac dans le PEV de routine - Le document de soumission pour l&apos;introduction de la deuxieme dose de RR est disponible et soumis &#xE0; GAVI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Appui technique au processus de relance de la vaccination de routine pour lesquelles UNICEF a le lead &#xE0; travers un suivi bas&#xE9; sur l&apos;elaboration du dashboard et des enquetes rapides de couvertures vaccinales 2. Appui technique pour la mise &#xE0; jour des documents de normes, standards et directives nationales pour la vaccination de routine prenant en compte les communaut&#xE9;s marginalis&#xE9;es ou non atteintes, y compris les strat&#xE9;gies innovantes et diffusion au niveau national 3..Appui technique &#xE0; la mise en oeuvre du plan d&apos;elimination de la rougeole, du tetanos maternel et neonatal, de controle de la fievre jaune y compris l&apos;introduction des nouveaux vaccins">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">?	L?introduction du vaccin Men Afrivac dans le PEV de routine n?est pas encore effective. Le chronogramme &#xE9;tabli a planifi&#xE9; l?introduction au cours du mois d?ao&#xFB;t 2021. Cependant il n?a pu &#xEA;tre respect&#xE9; &#xE0; cause des activit&#xE9;s du d&#xE9;ploiement de la vaccination contre la COVID-19, d&#xE9;marr&#xE9;es le 1 er avril, et la campagne de vaccination de masse contre la pand&#xE9;mie en cours dans le pays.
?	Concernant l&apos;introduction de la deuxi&#xE8;me dose de RR, les drafts des documents de soumission ont &#xE9;t&#xE9; &#xE9;labor&#xE9;s, la session de validation desdits documents par le Comit&#xE9; de Coordination Inter Agence (CCIA) planifi&#xE9;e pour septembre 2021 avant soumission &#xE0; GAVI n?a pu se tenir. Elle est planifi&#xE9;e pour le mois de d&#xE9;cembre 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">90% au moins de la cible ajust&#xE9;e des communes enr&#xF4;l&#xE9;es dans la mise en ?uvre de l&apos;approche sont vaccin&#xE9;s en Penta3</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;extension de l&apos;approche &quot;Atteindre Chaque Enfant B&#xE9;ninois &#xBB; par la suppression des causes d?in&#xE9;quit&#xE9; vaccinale&quot; &#xE0; toutes les communes du Benin">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Au 31 mai 2021, la cible ajust&#xE9;e en Penta3 est de 103,900 enfants. 70,713 enfants de la cible ont &#xE9;t&#xE9; vaccin&#xE9;s soit 68,1%.
(source : donn&#xE9;es Equivax/ANSSP).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;extension de l&apos;approche &quot;Atteindre Chaque Enfant B&#xE9;ninois &#xBB; par la suppression des causes d?in&#xE9;quit&#xE9; vaccinale&quot; &#xE0; toutes les communes du Benin">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Au 31 mai 2021, la cible ajust&#xE9;e en Penta3 est de 103,900 enfants. 70,713 enfants de la cible ont &#xE9;t&#xE9; vaccin&#xE9;s soit 68,1%.
(source : donn&#xE9;es Equivax/ANSSP).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des communes PEV du pays sont enr&#xF4;l&#xE9;es dans la mise en oeuvre de l&apos;approche 100%des microplans equit&#xE9; des communes enroll&#xE9;es sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au renforcement de la gestion du PEV de routine centr&#xE9; sur l&apos;equit&#xE9; dans les 12 d&#xE9;partements">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">En 2019. 32 communes couvertes par le PEV ont &#xE9;t&#xE9; enr&#xF4;l&#xE9;es dans l?approche &#xE9;quit&#xE9;. 
En 2020. Il &#xE9;tait pr&#xE9;vu l?extension dans 20 nouvelles communes. Cependant, &#xE0; cause de la COVID-19, seulement 16 communes ont &#xE9;t&#xE9; enr&#xF4;l&#xE9;es. 
En 2021. L?&#xE9;valuation du Plan de travail annuel (PTA) 2020 a permis d?identifier les 18 communes les moins performantes du pays. Le rapport des activit&#xE9;s du PEV 2020 est disponible.
Selon la nouvelle vision GAVI sur l?&#xE9;quit&#xE9; et les recommandations du dialogue multipartite, les communes couvertes par le PEV abritant &#xE0; la fois les enfants sous-vaccin&#xE9;s et les z&#xE9;ro-dose ont &#xE9;t&#xE9; identifi&#xE9;es.
En 2021, il est pr&#xE9;vu d?enr&#xF4;ler 55 communes (60% au lieu de 100% pr&#xE9;vu) ? les 16 communes enr&#xF4;l&#xE9;es en 2020, les 18 communes les moins performantes &#xE9;num&#xE9;r&#xE9;es dans le PTA 2021 et les communes couvertes par le PEV abritant &#xE0; la fois les enfants sous-vaccin&#xE9;s et les z&#xE9;ro-dose (rapport dialogue multipartite).
L?&#xE9;laboration des micro plans des communes enr&#xF4;l&#xE9;es a &#xE9;t&#xE9; retard&#xE9;e par les reports de la validation du PTA et l?&#xE9;laboration du rapport du dialogue multipartite.
Toutefois, les termes de r&#xE9;f&#xE9;rence (TdR) pour l?&#xE9;laboration des micro plans sont en cours de finalisation et seront transmis &#xE0; l?UNICEF.
Rapport d?activit&#xE9;s PEV 2020
https://drive.google.com/file/d/1shbxzlovdaOUydrH4P-mX5yQfuwWEy7N/view?usp=sharing 
Plan de travail annuel 2021
https://drive.google.com/file/d/1qhiolscO-4frPaLPzp3OMGcLrNTrg4tF/view?usp=sharing 
Rapport du Dialogue multipartite
https://drive.google.com/file/d/1XTqg7yDW8kpB2UpAQcosxxvIPTE3CVBL/view?usp=sharing</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au renforcement de la gestion du PEV de routine centr&#xE9; sur l&apos;equit&#xE9; dans les 12 d&#xE9;partements">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">En 2019. 32 communes couvertes par le PEV ont &#xE9;t&#xE9; enr&#xF4;l&#xE9;es dans l?approche &#xE9;quit&#xE9;. 
En 2020. Il &#xE9;tait pr&#xE9;vu l?extension dans 20 nouvelles communes. Cependant, &#xE0; cause de la COVID-19, seulement 16 communes ont &#xE9;t&#xE9; enr&#xF4;l&#xE9;es. 
En 2021. L?&#xE9;valuation du Plan de travail annuel (PTA) 2020 a permis d?identifier les 18 communes les moins performantes du pays. Le rapport des activit&#xE9;s du PEV 2020 est disponible.
Selon la nouvelle vision GAVI sur l?&#xE9;quit&#xE9; et les recommandations du dialogue multipartite, les communes couvertes par le PEV abritant &#xE0; la fois les enfants sous-vaccin&#xE9;s et les z&#xE9;ro-dose ont &#xE9;t&#xE9; identifi&#xE9;es.
En 2021, il est pr&#xE9;vu d?enr&#xF4;ler 55 communes (60% au lieu de 100% pr&#xE9;vu) ? les 16 communes enr&#xF4;l&#xE9;es en 2020, les 18 communes les moins performantes &#xE9;num&#xE9;r&#xE9;es dans le PTA 2021 et les communes couvertes par le PEV abritant &#xE0; la fois les enfants sous-vaccin&#xE9;s et les z&#xE9;ro-dose (rapport dialogue multipartite).
L?&#xE9;laboration des micro plans des communes enr&#xF4;l&#xE9;es a &#xE9;t&#xE9; retard&#xE9;e par les reports de la validation du PTA et l?&#xE9;laboration du rapport du dialogue multipartite.
Toutefois, les termes de r&#xE9;f&#xE9;rence (TdR) pour l?&#xE9;laboration des micro plans sont en cours de finalisation et seront transmis &#xE0; l?UNICEF.
Rapport d?activit&#xE9;s PEV 2020
https://drive.google.com/file/d/1shbxzlovdaOUydrH4P-mX5yQfuwWEy7N/view?usp=sharing 
Plan de travail annuel 2021
https://drive.google.com/file/d/1qhiolscO-4frPaLPzp3OMGcLrNTrg4tF/view?usp=sharing 
Rapport du Dialogue multipartite
https://drive.google.com/file/d/1XTqg7yDW8kpB2UpAQcosxxvIPTE3CVBL/view?usp=sharing</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">- 100% des formations sanitaires du Benin ont introduit le vaccin Men Afrivac dans le PEV de routine 
- Le document de soumission pour l&apos;introduction de la deuxieme dose de RR est disponible et soumis &#xE0; GAVI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Appui technique au processus de relance de la vaccination de routine pour lesquelles UNICEF a le lead &#xE0; travers un suivi bas&#xE9; sur l&apos;elaboration du dashboard et des enquetes rapides de couvertures vaccinales 
2. Appui technique pour la mise &#xE0; jour des documents de normes, standards et directives nationales pour la vaccination de routine prenant en compte les communaut&#xE9;s marginalis&#xE9;es ou non atteintes, y compris les strat&#xE9;gies innovantes et diffusion au niveau national 
3..Appui technique &#xE0; la mise en oeuvre du plan d&apos;elimination de la rougeole, du tetanos maternel et neonatal, de controle de la fievre jaune y compris l&apos;introduction des nouveaux vaccins">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">La mini campagne du vaccin MenA a &#xE9;t&#xE9; suspendue pour faire place &#xE0; l?introduction du vaccin contre le COVID-19 et la campagne de riposte polio r&#xE9;alis&#xE9;e en deux passages.
Les activit&#xE9;s ont repris avec la conception des outils de communication.
La demande pour l?introduction de la deuxi&#xE8;me dose de vaccin contre la rougeole et rub&#xE9;ole (RR) n?a pas &#xE9;t&#xE9; faite en 2020 du aux contraintes li&#xE9;es &#xE0; la r&#xE9;ponse &#xE0; la COVID-19 et la campagne de riposte polio. De plus, cette activit&#xE9; a &#xE9;t&#xE9; attribu&#xE9;e &#xE0; l?OMS dans le plan GAVI TCA 2021.
Plan d?action Campagne MEN 2019
https://drive.google.com/file/d/11hE8mVCl5hJLPwAKjNv0ljIYueeDNfVP/view?usp=sharing 
Plan de communication Campagne MEN
https://drive.google.com/file/d/1RG553DWI5yHgNQCBrmasUgGfzaGHA45V/view?usp=sharing 
GAVI Targeted country assistance plan Benin 2020 https://drive.google.com/file/d/1i_m8asOip5ES17VE7oZbAaSvb6onGD9E/view?usp=sharing</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Appui technique au processus de relance de la vaccination de routine pour lesquelles UNICEF a le lead &#xE0; travers un suivi bas&#xE9; sur l&apos;elaboration du dashboard et des enquetes rapides de couvertures vaccinales 
2. Appui technique pour la mise &#xE0; jour des documents de normes, standards et directives nationales pour la vaccination de routine prenant en compte les communaut&#xE9;s marginalis&#xE9;es ou non atteintes, y compris les strat&#xE9;gies innovantes et diffusion au niveau national 
3..Appui technique &#xE0; la mise en oeuvre du plan d&apos;elimination de la rougeole, du tetanos maternel et neonatal, de controle de la fievre jaune y compris l&apos;introduction des nouveaux vaccins">
      <location ref="BJ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">La mini campagne du vaccin MenA a &#xE9;t&#xE9; suspendue pour faire place &#xE0; l?introduction du vaccin contre le COVID-19 et la campagne de riposte polio r&#xE9;alis&#xE9;e en deux passages.
Les activit&#xE9;s ont repris avec la conception des outils de communication.
La demande pour l?introduction de la deuxi&#xE8;me dose de vaccin contre la rougeole et rub&#xE9;ole (RR) n?a pas &#xE9;t&#xE9; faite en 2020 du aux contraintes li&#xE9;es &#xE0; la r&#xE9;ponse &#xE0; la COVID-19 et la campagne de riposte polio. De plus, cette activit&#xE9; a &#xE9;t&#xE9; attribu&#xE9;e &#xE0; l?OMS dans le plan GAVI TCA 2021.
Plan d?action Campagne MEN 2019
https://drive.google.com/file/d/11hE8mVCl5hJLPwAKjNv0ljIYueeDNfVP/view?usp=sharing 
Plan de communication Campagne MEN
https://drive.google.com/file/d/1RG553DWI5yHgNQCBrmasUgGfzaGHA45V/view?usp=sharing 
GAVI Targeted country assistance plan Benin 2020 https://drive.google.com/file/d/1i_m8asOip5ES17VE7oZbAaSvb6onGD9E/view?usp=sharing</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">76% des communes PEV du pays sont enr&#xF4;l&#xE9;es dans la mise en oeuvre de l&apos;approche 100%des microplans equit&#xE9; des communes enroll&#xE9;es sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au renforcement de la gestion du PEV de routine centr&#xE9; sur l&apos;equit&#xE9; dans les 12 d&#xE9;partements">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Nous utilisons le status re-programmed car loption non - applicable nest pas disponible.
Ce milestone nest pas applicable pour la raison suivante:
Ce milestone est une duplication du milestone 3 avec une couverture qui ne correspond pas au plan TCA 2020 approuv&#xE9; pour l?UNICEF.
Targeted country assistance plan Benin 2020. https://drive.google.com/file/d/1i_m8asOip5ES17VE7oZbAaSvb6onGD9E/view?usp=sharing</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% des actiivt&#xE9;s du PITA PEV National centr&#xE9; sur l&apos;equit&#xE9; sont execut&#xE9;es 100% des formations sanitaires du Benin ont introduit le Vaccin Hepatite B &#xE0; la naissance dans le PEV de routine</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Appui technique au processus de relance de la vaccination de routine pour lesquelles UNICEF a le lead &#xE0; travers un suivi bas&#xE9; sur l&apos;elaboration du dashboard et des enquetes rapides de couvertures vaccinales 2. Appui technique pour la mise &#xE0; jour des documents de normes, standards et directives nationales pour la vaccination de routine prenant en compte les communaut&#xE9;s marginalis&#xE9;es ou non atteintes, y compris les strat&#xE9;gies innovantes et diffusion au niveau national 3..Appui technique &#xE0; la mise en oeuvre du plan d&apos;elimination de la rougeole, du tetanos maternel et neonatal, de controle de la fievre jaune y compris l&apos;introduction des nouveaux vaccins">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Sur les 100 activit&#xE9;s inscrites au plan de travail de 2020, 55 ont &#xE9;t&#xE9; ex&#xE9;cut&#xE9;es, soit 55%.
Seulement 1 activit&#xE9; sur 2 a &#xE9;t&#xE9; ex&#xE9;cut&#xE9;e, soit 50% des activit&#xE9;s du PTA PEV national centr&#xE9; sur l&apos;&#xE9;quit&#xE9;. Ce retard est d&#xFB; par la validation du PTA PEV 2020, la survenue de la COVID-19, la non-approbation du budget RSS2 2020-2021par GAVI et la restructuration de l?&#xE9;quipe du PEV au niveau central.
R&#xE9;alisations de l?ann&#xE9;e 2020 sont les suivantes : 
?	L?introduction de la dose du vaccin contre l?h&#xE9;patite B (DN HepB) &#xE0; la naissance
?	L?acquisition de 482 &#xE9;quipements de chaine de froid dans le cadre de la r&#xE9;alisation de l?ann&#xE9;e 1 du CCEOP
?	La formation de 590 aides-soignants sur la surveillance des maladies &#xE9;vitables par la vaccination (MEV) et la vaccination de routine 
?	La formation de 46 agents charg&#xE9;s de la surveillance des MEV 
?	L?&#xE9;laboration des proc&#xE9;dures op&#xE9;ratoires normalis&#xE9;es pour la gestion des vaccins 
?	L?inventaire des &#xE9;quipements de la chaine de froid 
Le vaccin DN HepB &#xE0; la naissance a &#xE9;t&#xE9; introduit depuis le 1er octobre 2020 dans le PEV de routine dans 100% des formations sanitaires.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete trainings on data management and analysis processes; Complete supervision visits to at least 2 sites; Complete analysis &gt;90% of specimens collected in 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Benin MOH and National Reference Laboratory, CDC/DBD proposes the following activities to strengthen laboratory systems, vaccine preventable diseases surveillance including meningitis, an epidemic prone disease, and assist the early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance at national and regional levels; 2) reinforce quality control programs to ensure laboratory proficiency in regions at high risk; 3) improve lab data management, analysis, and reporting practices.">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020, and supervisory trainings on meningitis diagnosis and specimen transport were completed in December 2020 (15-16 Dec 2020). A total of 20 laboratory scientists were trained from 3 regions (Atacora-Donga, Borgou-Alibori and Zou) to improve laboratory confirmation for case-based meningitis surveillance. Supervisory training topics include importance of bacterial meningitis surveillance, data harmonization, laboratory biosafety, PCR confirmation and culture, Specimen handling and transport; Quantitative Cytology, and Gram Stain. Benin is on the right track completing the testing and analysis of all specimens.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Benin MOH and National Reference Laboratory, CDC/DBD proposes the following activities to strengthen laboratory systems, vaccine preventable diseases surveillance including meningitis, an epidemic prone disease, and assist the early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance at national and regional levels; 2) reinforce quality control programs to ensure laboratory proficiency in regions at high risk; 3) improve lab data management, analysis, and reporting practices.">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020, and supervisory trainings on meningitis diagnosis and specimen transport were completed in December 2020 (15-16 Dec 2020). A total of 20 laboratory scientists were trained from 3 regions (Atacora-Donga, Borgou-Alibori and Zou) to improve laboratory confirmation for case-based meningitis surveillance. Supervisory training topics include importance of bacterial meningitis surveillance, data harmonization, laboratory biosafety, PCR confirmation and culture, Specimen handling and transport; Quantitative Cytology, and Gram Stain. Benin is on the right track completing the testing and analysis of all specimens.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete training of national and &gt;2 regional labs on detection of bacterial meningitis using the latest effective technology and on specimen management; Implement in-country quality programs to ensure lab proficiency; Complete analysis &gt;90% of specimens collected between Jan-Aug 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Benin MOH and National Reference Laboratory, CDC/DBD proposes the following activities to strengthen laboratory systems, vaccine preventable diseases surveillance including meningitis, an epidemic prone disease, and assist the early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance at national and regional levels; 2) reinforce quality control programs to ensure laboratory proficiency in regions at high risk; 3) improve lab data management, analysis, and reporting practices.">
      <location ref="BJ"></location>
     </target>
     <actual value="On Track">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on meningitis diagnosis and specimen transport were completed in December 2020 (15-16 Dec 2020). A total of 20 laboratory scientists from 3 regions (Atacora-Donga, Borgou-Alibori and Zou) were trained to improve laboratory confirmation for case-based meningitis surveillance. The main topics covered included importance of bacterial meningitis surveillance, data harmonization, laboratory biosafety, PCR confirmation, culture, specimen handling and transport; Quantitative Cytology, and Gram Stain. The in-country quality programs focusing on Gram Stain in districts was completed in May 2021. All specimens received at national level were tested by PCR. UPDATED REPORT FOR PEF TF 21.1.1 (Unable to add since already submitted): Trainings on data management and lab processes were completed in December 2020. Topics covered specimen accessioning, data reporting and analysis, scientific data summary and interactive sessions. Post-trainings supervisory visits were completed in March 2021. Benin is on the right track completing the testing and analysis of all specimens.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">GaneshAid : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">One training report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.5 Train the facilitators of the Community of Practices from ANSSP">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.5 Train the facilitators of the Community of Practices from ANSSP">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training of EPI teams and IT teams on the management of the PWC and the use of the C2P mobile application.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.2 Training of EPI teams and IT teams on the management of the PWC and the use of the C2P mobile application.">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.2 Training of EPI teams and IT teams on the management of the PWC and the use of the C2P mobile application.">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Software maintenance and update report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.3 Provide IT technical assistance, software maintenance and updates.">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Testing report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.2 Identify/brief/monitor testers in the country. 3.3 Using remote usage tests to verify the C2P digital solution is easy to use (Pilot test).">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.2 Identify/brief/monitor testers in the country.
3.3 Using remote usage tests to verify the C2P digital solution is easy to use (Pilot test).">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Troubleshooting and upgrade plans</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.4 Troubleshooting and upgrade plans.">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on results of C2P to improve the performance of EPI staff.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.1 Document the results of C2P to improve the performance of EPI staff.
4.2 Measure the level of acceptance of the performance coaching methodology and the use of a digital solution for supportive supervision.">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">C2P national scale up plan/strategy/roadmap</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.3 Definition of the scale-up plan / strategy, including training of supervisors and monitoring. 4.4 The participation of the main stakeholders and partners in the countries for the ownership and sustainability of C2P in supportive supervision.">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.3 Definition of the scale-up plan / strategy, including training of supervisors and monitoring.
4.4 The participation of the main stakeholders and partners in the countries for the ownership and sustainability of C2P in supportive supervision.">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Project Advisory Group/CCP meetings/calls agendas and reports</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.1 Project management">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.1 Project management">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.1 Project management">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">#NAME?</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.3 Monitoring and evaluation">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.3 Monitoring and evaluation">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.3 Monitoring and evaluation">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">AMP : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of health zones having carried out at least 1 DQS / LQAS,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1, 2 and 3">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e dans le TCA 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1, 2 and 3">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e dans le TCA 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of health zones having performed monthly verification, data analysis</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1, 2 and 3">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e dans le TCA 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1, 2 and 3">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e dans le TCA 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 2 of quarterly data harmonization meetings carried out.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1, 2 and 3">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e dans le TCA 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1, 2 and 3">
      <location ref="BJ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e dans le TCA 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of health zones having implemented  the current health accountability framework,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1, 2 and 3">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Ce qui est fait :
-	Analyse situation des RHS y compris l?analyse du de redevabilit&#xE9; actuel r&#xE9;alis&#xE9;e
-	Base de donn&#xE9;es des acteurs de la vaccination disponible
-	Analyse de situation de besoins de formation
-	Plan renforcement capacit&#xE9;s 
-	Document d?op&#xE9;rationnalisation cadre redevabilit&#xE9; PEV . Le cadre de performance valid&#xE9; avec Gavi est celui retenu pour le DG/ANSSP et le DVL
Prochaines &#xE9;tapes
-	Validation et mise en ?uvre cadre redevabilit&#xE9;
-	Mise en ?uvre plan de renforcement des capacit&#xE9;s</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1, 2 and 3">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Ce qui est fait :
-	Analyse situation des RHS y compris l?analyse du de redevabilit&#xE9; actuel r&#xE9;alis&#xE9;e
-	Base de donn&#xE9;es des acteurs de la vaccination disponible
-	Analyse de situation de besoins de formation
-	Plan renforcement capacit&#xE9;s 
-	Document d?op&#xE9;rationnalisation cadre redevabilit&#xE9; PEV . Le cadre de performance valid&#xE9; avec Gavi est celui retenu pour le DG/ANSSP et le DVL
Prochaines &#xE9;tapes
-	Validation et mise en ?uvre cadre redevabilit&#xE9;
-	Mise en ?uvre plan de renforcement des capacit&#xE9;s</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of health zones having implemented the current health accountability framework,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Objective 1, 2 and 3">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Rescheduled on T3 2021 due to in-country actors agenda</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed
2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="BJ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BJ"></location>
      <comment>
       <narrative xml:lang="EN">Rescheduled on T3 due to in-country actors agenda</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed 2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on VPD surveillance digital data package and know how to use it.
Costed scale up plan exist.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="BJ"></location>
     </target>
     <actual>
      <location ref="BJ"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
